Treatment pathways and associated costs of metastatic colorectal cancer in Greece.

Sougklakos, Ioannis; Athanasiadis, Elias; Boukovinas, Ioannis; Karamouzis, Michalis; Koutras, Aggelos; Papakotoulas, Paulos; Latsou, Dimitra; Hatzikou, Magda; Stamuli, Eugena; Balasopoulos, Athanasios; Sideris, Aggelos

Sougklakos, Ioannis; Athanasiadis, Elias; Boukovinas, Ioannis; Karamouzis, Michalis; Koutras, Aggelos; Papakotoulas, Paulos; Latsou, Dimitra; Hatzikou, Magda; Stamuli, Eugena; Balasopoulos, Athanasios; Sideris, Aggelos.

Afiliación

Sougklakos I; Laboratory of Translation Oncology, University Hospital of Crete Medical School, Crete, Greece.
Athanasiadis E; Ygeia Athens Hospital, Marousi, Greece.
Boukovinas I; Bioclinic Oncology Department Thessaloniki, Thessaloniki, Greece.
Karamouzis M; Molecular Oncology Unit, Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Koutras A; University of Patras, Patras, Greece.
Papakotoulas P; Theagenion Anticancer Hospital, Thessaloniki, Greece.
Latsou D; Pharmecons Easy Access, Athens, Greece.
Hatzikou M; Pharmecons Easy Access, Athens, Greece. magda.chatzikou@pharmecons.com.
Stamuli E; Pharmecons Easy Access, Athens, Greece.
Balasopoulos A; Pierre Fabre Farmaka S.A., Agia Paraskevi, Greece.
Sideris A; Pierre Fabre Farmaka S.A., Agia Paraskevi, Greece.

Cost Eff Resour Alloc ; 20(1): 7, 2022 Feb 14.

Article en En | MEDLINE | ID: mdl-35164784

Palabras clave

Braf600 mutation; Costs; Disease burden; Greece; Metastatic colorectal cancer; Treatment pathways

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Cost Eff Resour Alloc Año: 2022 Tipo del documento: Article País de afiliación: Grecia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google